1. Whole transcriptome analysis identifies differentially regulated networks between osteosarcoma and normal bone samples
    Xuan Dung Ho et al, 2017, Experimental Biology and Medicine CrossRef
  2. DNA damage response and repair in osteosarcoma: Defects, regulation and therapeutic implications
    Fatemeh Sadoughi et al, 2021, DNA Repair CrossRef
  3. Hsa_circ_0064636 regulates voltage dependent anion channel 1/ubiquitination factor E4A through miR‑326/miR‑503‑5 in osteosarcoma
    Guohua Yan et al, 2024, Oncology Letters CrossRef
  4. SIX1 reduces the expression of PTEN via activating PI3K/AKT signal to promote cell proliferation and tumorigenesis in osteosarcoma
    Chao Yu et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  5. Hypoxia-inducible factor-1 promotes cancer progression through activating AKT/Cyclin D1 signaling pathway in osteosarcoma
    Bo Zhang et al, 2018, Biomedicine & Pharmacotherapy CrossRef
  6. Cytotoxic Tolerance of Healthy and Cancerous Bone Cells to Anti-microbial Phenolic Compounds Depend on Culture Conditions
    Ozge Karadas et al, 2019, Applied Biochemistry and Biotechnology CrossRef
  7. Paget’s Disease of the Bone and Lynch Syndrome: An Exceptional Finding
    Ana-Maria Gheorghe et al, 2023, Diagnostics CrossRef
  8. Predicting novel genes and pathways associated with osteosarcoma by using bioinformatics analysis
    Bo Dong et al, 2017, Gene CrossRef
  9. Anticancer Effects of Constituents of Herbs Targeting Osteosarcoma
    Qing-hong Su et al, 2019, Chinese Journal of Integrative Medicine CrossRef
  10. Circular RNAs hsa_circ_0032462, hsa_circ_0028173, hsa_circ_0005909 are predicted to promote CADM1 expression by functioning as miRNAs sponge in human osteosarcoma
    Gaoyang Chen et al, 2018, PLOS ONE CrossRef
  11. PAIP1 is a novel oncogene in human hepatocellular carcinoma
    Nuobei Zhang et al, 2022, Discover Oncology CrossRef
  12. Retracted: Long non‐coding RNA PGM5‐AS1 promotes epithelial‐mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR‐140‐5p‐mediated FBN1 inhibition
    Wei Liu et al, 2020, Molecular Oncology CrossRef